Differential expression of proteins in brain regions of alzheimer's disease patients

Neurochemical Research

Volumn 39, Issue 1, 2014, Pages 208-215

  Zahid, Saadia ^a,b,c   Oellerich, Michael ^b   Asif, Abdul R ^b   Ahmed, Nikhat ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Alzheimer's disease; Cortex; Hippocampus; Neurodegeneration; Proteomics; Substantia nigra

Indexed keywords

ACONITATE HYDRATASE; CALBINDIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN; CREATINE KINASE; DIHYDROLIPOAMIDE DEHYDROGENASE; ELONGATION FACTOR TU; FASCIN; FUMARATE HYDRATASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE DEAMINASE; HEAT SHOCK PROTEIN; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 1; LACTOYLGLUTATHIONE LYASE; LANC LIKE PROTEIN 1; LIPOCORTIN 5; MALATE DEHYDROGENASE; N ETHYLMALEIMIDE SENSITIVE FACTOR; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE B; PROLYL ENDOPEPTIDASE; PROTEIN 14 3 3; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SYNAPSIN; SYNAPSIN I; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DOWN REGULATION; ELECTROSPRAY; ENERGY METABOLISM; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBRAL CORTEX; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANTIA NIGRA; TRANSCRIPTOME;

EID: 84892677529     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1210-1     Document Type: Article

References (29)

1. Aitken A, Collinge DB, van Heusden BP, Isobe T, Roseboom PH, Rosenfeld G, Soll J (1992) 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 17:498-501
2. Asif AR, Oellerich M, Amstrong VW, Gross U, Reichard U (2010) Analysis of the cellular Aspergillus fumigatus proteome that reacts with sera from rabbits developing an acquired immunity after experimental aspergillosis. Electrophoresis 31:1947-1958
3. Bekris LM, Yu CE, Bird TD, Tsuang DW (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 23:213-227
4. Blum H, Beier H, Gross HJ (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8:93-99
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
6. Bürklen TS, Schlattner U, Homayouni R, Gough K, Rak M, Szeghalmi A, Wallimann T (2006) The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits. J Biomed Biotechnol 2006:35936
7. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85:1394-1401 (Pubitemid 36702552)
8. Chuang DM, Hough C, Senatorov VV (2005) Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45:269-290 (Pubitemid 40261806)
9. Cumming RC, Schubert D (2005) Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J 19:2060-2062 (Pubitemid 41759765)
10. Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78:151-164 (Pubitemid 17031709)
11. Ferreira IL, Resende R, Ferreiro E, Ergo AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 11:1193-1206
12. Gandy S (2005) The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 115:1121-1129 (Pubitemid 40629026)
13. Gohla A, Bokoch GM (2002) 14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin. Curr Biol 12:1704-1710 (Pubitemid 35161927)
14. Halpain S, Hipolito A, Saffer L (1998) Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 18:9835-9844 (Pubitemid 28543762)
15. Holtzman DM, Morris JC, Goate AM (2011) Alzheimer's disease: the challenge of the second century. Sci Transl Med 3:77sr1
16. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C (2009) STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: (Database issue) D412-D416
17. Mazzola JL, Sirover MA (2001) Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J Neurochem 76:442-449 (Pubitemid 32097022)
18. Naletova I, Schmalhausen E, Kharitonov A, Katrukha A, Saso L, Caprioli A, Muronetz V (2008) Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures. Biochim Biophys Acta 1784:2052-2058
19. Obulesu M, Venu R, Somashekhar R (2011) Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology. Neurochem Res 36:1329-1335
20. Planel E, Miyasaka T, Launey T, Chui DH, Tanemura K, Sato S, Murayama O, Ishiguro K, Tatebayashi Y, Takashima A (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 24:2401-2411 (Pubitemid 38327953)
21. Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE (2003) Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci USA 100:4837-4842 (Pubitemid 36457815)
22. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137-152
23. Rhein V, Baysang G, Rao S, Meier F, Bonert A, Müller-Spahn F, Eckert A (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 29:1063-1071
24. Rinne JO, Rummukainen J, Paljärvi L, Säkö E, Mölsä P, Rinne UK (1989) Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia. Prog Clin Biol Res 317:325-332
25. Roth D, Birkenfeld J (1999) Betz H dominant-negative alleles of 14-3-3 proteins cause defects in actin organization and vesicle targeting in the yeast Saccharomyces cerevisiae. FEBS Lett 460:411-416 (Pubitemid 29518410)
26. Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA (2007) Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis 11:153-164 (Pubitemid 47010980)
27. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T, Ikeda K, Takasaki M (2004) 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol 108:279-286 (Pubitemid 39317695)
28. Werner CJ, Heyny-von Haussen R, Mall G, Wolf S (2008) Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci 6:8 (Pubitemid 351385673)
29. Zahid S, Oellerich M, Asif AR, Ahmed N (2012) Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients. J Neurochem 121:954-963